Global Vascular Access Sheaths Market Size By Type (Intravenous Catheter Sheaths, Synthetic Graft Sheaths), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Vascular Access Sheaths Market was valued at USD 876 million in 2023 and is projected to reach USD 1.45 billion by 2031, growing at a CAGR of 6.6% during the forecast period from 2023 to 2031. Vascular access sheaths are essential tools in minimally invasive cardiovascular and endovascular procedures, enabling safe and efficient insertion of diagnostic and therapeutic catheters. The market's growth is fueled by the rising prevalence of cardiovascular diseases, increasing number of interventional procedures, and growing adoption of minimally invasive techniques globally.

Drivers

Rising Prevalence of Cardiovascular Diseases:

A surge in the global burden of cardiovascular conditions, including coronary artery disease and peripheral artery disease, is significantly increasing the demand for vascular interventions, subsequently driving the demand for vascular access sheaths.

Growth in Minimally Invasive Surgeries:

The global healthcare landscape is witnessing a shift towards minimally invasive procedures due to advantages such as reduced recovery time, shorter hospital stays, and minimal post-operative complications. Vascular access sheaths are critical to these interventions, boosting their market uptake.

Technological Advancements in Sheath Design:

Innovations such as hydrophilic coatings, reinforced materials, and hemostatic valves are enhancing the performance and safety of vascular access sheaths. These advancements are encouraging wider adoption across hospitals and catheterization labs.

Restraints

Risk of Access-Site Complications:

Despite their utility, vascular access sheaths can cause complications such as bleeding, infection, and vessel trauma, which may hinder market adoption in some clinical settings.

High Cost of Advanced Products:

Premium vascular access sheaths with advanced features come at a higher cost, which may be a barrier for underfunded healthcare facilities, particularly in developing economies.

Opportunity

Expanding Geriatric Population and Chronic Disease Burden:

With the global rise in aging populations, the incidence of cardiovascular and chronic conditions requiring interventional procedures is increasing, creating substantial growth opportunities for market players.

Emerging Markets in Asia-Pacific and Latin America:

The rapid development of healthcare infrastructure in emerging regions, combined with increasing awareness and access to advanced cardiovascular care, offers promising opportunities for market expansion.

Market by System Type Insights

By system type, introducer sheaths held the largest market share in 2023 due to their wide use in percutaneous interventions. Their ability to provide stable access during complex procedures makes them indispensable in both diagnostic and therapeutic applications. Meanwhile, valved sheaths are projected to register the highest growth rate during the forecast period, thanks to their enhanced safety profile and reduced risk of air embolism or blood loss.

Market by End-use Insights

Hospitals and cardiac catheterization laboratories emerged as the dominant end-users in 2023, together accounting for over 60% of the market share. The increasing number of angiographic and electrophysiological procedures performed in these facilities contributes to high product utilization. Ambulatory surgical centers (ASCs) are expected to witness notable growth due to increasing procedural volume shifting towards outpatient settings.

Market by Regional Insights

North America led the global vascular access sheaths market in 2023, driven by advanced healthcare infrastructure, high procedural volumes, and favorable reimbursement scenarios. However, Asia-Pacific is anticipated to be the fastest-growing region during the forecast period, owing to improving healthcare accessibility, rising cardiovascular disease burden, and an expanding base of trained interventional cardiologists.

Competitive Scenario

Key players in the Global Vascular Access Sheaths Market include Terumo Corporation, Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Cardinal Health, Merit Medical Systems, Inc., Teleflex Incorporated, Cook Medical, and Biotronik SE & Co. KG. These companies are actively engaged in product development, strategic partnerships, and global expansion to consolidate their market positions.

Recent Developments:

In 2024, Terumo launched a next-generation radial access sheath featuring ultra-thin walls and increased flexibility to support complex coronary interventions.

Boston Scientific received FDA clearance in 2023 for its novel hemostatic introducer sheath designed to minimize bleeding complications.

Medtronic expanded its vascular access product line in 2023 with a sheath specifically engineered for large-bore interventions.

Scope of Work – Global Vascular Access Sheaths Market

Report Metric Details

Market Size (2023) USD 876 million

Projected Market Size (2031) USD 1.45 billion

CAGR (2023–2031) 6.6%

Market Segments By System Type (Introducer Sheaths, Valved Sheaths), End-use (Hospitals, Cardiac Cath Labs, ASCs), Region

Growth Drivers Rising cardiovascular procedures, technological innovations, preference for minimally invasive techniques

Opportunities Emerging markets expansion, aging population, growth in outpatient interventions

Key Market Developments

2024: Terumo unveiled an advanced introducer sheath with ultra-low profile technology to minimize arterial trauma.

2023: Boston Scientific secured regulatory approval for its sheath equipped with enhanced hemostasis technology.

2023: Teleflex collaborated with leading hospitals to test biodegradable sheath prototypes in clinical trials.

FAQs

What is the current market size of the Global Vascular Access Sheaths Market?

The market was valued at USD 876 million in 2023.

What is the major growth driver of the Global Vascular Access